For us progress means research. Specialized scientists with years of experience and commitment to the development of new pharmaceuticals, work together to take healthcare a step further.

We support this effort by investing in research and development approximately 6% of our turnover.

Our researchers executes every phase of the development process with the utmost care, including identification of reliable suppliers of active ingredients, realization of laboratory and industrial-scale trial batches, development and validation of analytical methods and stability studies.

Our bioequivalence studies are performed in cooperation with world-class CROs (Contract Research Organizations).

The result of this dynamic activity is the steady flow of state-of-the-art registration dossiers, which are used by us, our licensees and distributors to acquire marketing authorizations from the most demanding regulatory authorities worldwide.

Besides its own independent activity, RAFARM cooperates with University Foundations (Athens, Patra, Crete, Ioannina), on joint research projects, since the 90’s.

The company’s annual investments in research represent approximately 6% of the turnover.

footerlogo Copyright Rafarm © 2014
All rights reserved